IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.610
-0.040 (-2.42%)
May 12, 2025, 4:00 PM - Market closed

IM Cannabis Revenue

In the year 2024, IM Cannabis had annual revenue of 54.03M CAD with 10.71% growth. IM Cannabis had revenue of 13.34M in the quarter ending December 31, 2024, with 24.65% growth.

Revenue (ttm)
54.03M CAD
Revenue Growth
+10.71%
P/S Ratio
0.13
Revenue / Employee
568,747 CAD
Employees
95
Market Cap
4.87M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.03M5.23M10.71%
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings